A Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune Diseases and Atherosclerosis

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Exclusion</td><td align="left">Inclusion</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Unrelated to topical Lp(a) and autoimmune disease and atherosclerosis and CVD considered as not relevant</td><td align="left">Autoimmune disorders: antiphospholipid (Hughes) syndrome (APS), rheumatoid arthritis, Sjögren’s syndrome, systemic lupus erythematosus, systemic sclerosis, and systemic vasculitis</td></tr><tr><td align="left">Unpublished studies</td><td align="left">Published between 1991 and 2011</td></tr><tr><td align="left">Single case studies</td><td align="left"> </td></tr><tr><td align="left">Available not as full text (reprints were requested) </td><td align="left"> </td></tr><tr><td align="left">Dissertations or theses or book chapters</td><td align="left"> </td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Exclusion and inclusion criteria of review.

International Journal of Rheumatology

tab1

Table 1

Table 1: A Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune Diseases and Atherosclerosis 